Viewing Study NCT02012192


Ignite Creation Date: 2025-12-24 @ 3:52 PM
Ignite Modification Date: 2026-03-08 @ 5:43 AM
Study NCT ID: NCT02012192
Status: TERMINATED
Last Update Posted: 2019-08-13
First Post: 2013-12-02
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer
Sponsor: Medical University Innsbruck
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: GANNET53
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View